KETOROLAC TROMETHAMINE INJECTION, USP
Analogs of KETOROLAC TROMETHAMINE INJECTION, USP
Find cheaper analogs and generic equivalents for KETOROLAC TROMETHAMINE INJECTION, USP.
Active Ingredient: KETOROLAC TROMETHAMINE
Product Overview
About KETOROLAC TROMETHAMINE INJECTION, USP
KETOROLAC TROMETHAMINE INJECTION, USP is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe pain. It is administered via injection and is available in various concentrations.
Key Benefits & Uses
- Management of moderate to severe pain, including acute pain in adults and postoperative pain.
- Treatment of moderate to severe pain in patients who require analgesia at the opioid level, usually in a postoperative setting or for acute pain not responsive to non-narcotic analgesics.
- Reduction of inflammation and relief of pain in patients with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Active Ingredient & Action
KETOROLAC TROMETHAMINE is a potent inhibitor of prostaglandin synthesis. It works by blocking the enzyme cyclooxygenase (COX), which is responsible for the production of prostaglandins. Prostaglandins are mediators of inflammation and pain, and by inhibiting their production, KETOROLAC TROMETHAMINE reduces inflammation and provides pain relief.
Important Notes
It is essential to use KETOROLAC TROMETHAMINE INJECTION, USP as directed by a healthcare professional. The recommended dosage and duration of treatment should be followed carefully. Patients with a history of gastrointestinal bleeding or ulcers, kidney disease, or liver disease should use this medication with caution. Additionally, KETOROLAC TROMETHAMINE INJECTION, USP may interact with other medications, including blood thinners, and may increase the risk of bleeding. Patients should inform their healthcare provider of all medications they are taking before starting treatment with KETOROLAC TROMETHAMINE INJECTION, USP.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.